ATHA

Athira Pharma (ATHA)

About Athira Pharma (ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Details

Daily high

$0.57

Daily low

$0.52

Price at open

$0.55

52 Week High

$4.30

52 Week Low

$0.41

Market cap

21.5M

Dividend yield

0.00%

Volume

89,190

Avg. volume

188,609

P/E ratio

-.19

Athira Pharma News